On January 31st, Novo Nordisk released its 2023 results, with annual revenue of approximately $33.771 billion, a year-on-year increase of 31%. As a star product of Novo Nordisk, Smegglutide earned ap ...

The foreign exchange market has also undergone significant changes in the short term. The weak yen reversed due to the Bank of Japan's unexpected interest rate hike at the end of July, but weakened a ...

Guosheng Securities released a research report stating that behind Nvidia's financial report is the long-term sustainability and growth of AI hardware demand. From various perspectives such as techno ...